Alcohol and nutrition as risk factors for chronic liver disease

Nutrition and Alcohol: Linking Nutrient Interactions and Dietary Intake

Volumn , Issue , 2003, Pages 73-86

  Bellentani, Stefano ^a   Tiribelli, Claudio ^a,b   Bedogni, Giorgio ^c  

^a Fondo Studi Fegato   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 31544454925     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (61)

1. Friedman S.L. Liver fibrosis — from bench to bedside. J. Hepatol., 38 Suppl 1, S38, 2003.
2. Paradis V. et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology, 34, 738, 2001.
3. Diehl A.M. Alcoholic liver disease. Med. Clin. North. Am., 73, 815, 1989.
4. Bunout D. Nutritional and metabolic effects of alcoholism: their relationship with alcoholic liver disease. Nutrition, 15, 583, 1999.
5. Derr R.F. et al. Is ethanol per se hepatotoxic? J. Hepatol., 10, 381, 1990.
6. Bellentani S. et al. Drinking habits as cofactors of risk for alcohol induced liver damage: the Dionysos Study Group. Gut, 41, 845, 1997.
7. Devor E.J. et al. Genetics of alcoholism and related end-organ damage. Semin. Liver Dis., 8, 1, 1988.
8. Davis M. Alcoholic liver injury. Proc. Nutr. Soc., 47, 115, 1988.
9. Day C.P et al. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology, 14, 798, 1991.
10. Chao Y.C. et al. Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients. Hepatology, 25, 112, 1997.
11. Poupon R.E. et al. Polymorphism of alcohol dehydrogenase, alcohol and aldehyde dehydrogenase activities: implication in alcoholic cirrhosis in white patients. The French Group for Research on Alcohol and Liver. Hepatology, 15, 1017, 1992.
12. Tsutsumi M. et al. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology, 107, 1430, 1994.
13. Savolainen V.T. et al. Polymorphism in the cytochrome P4502E1 gene and the risk of alcoholic liver disease. J. Hepatol., 26, 55, 1997.
14. Pirmohamed M. et al. Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics, 5, 351, 1995.
15. Yamauchi M. et al. Association of a restriction fragment length polymorphism in the alcohol dehydrogenase 2 gene with Japanese alcoholic liver cirrhosis. J. Hepatol., 23, 519, 1995.
16. Day C.P et al. Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosis. Hepatology, 18, 230, 1993.
17. Bellentani S. et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology, 20, 1442, 1994.
18. Corrao G. et al. Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy. J. Hepatol., 28, 608, 1998.
19. Sorensen T.I. et al. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet, 2, 241, 1984.
20. Coates R.A. et al. Risk of fatty infiltration or cirrhosis of the liver in relation to ethanol consumption: a case-control study. Clin. Invest. Med., 9, 26, 1986.
21. Klatsky A.L. et al. Alcohol and mortality. Ann. Intern. Med., 117, 646, 1992.
22. Klatskin G. Alcohol and its relation to liver disease. Gastroenterology, 41, 443, 1961.
23. Lieber C.S. Alcohol and the liver: 1994 update. Gastroenterology, 106, 1085, 1994.
24. Becker U. et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology, 23, 1025, 1996.
25. Grant B.F. et al. Epidemiology of alcoholic liver disease. Semin. Liver Dis., 8, 12, 1988.
26. Lelbach W.K. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann. N.Y. Acad. Sci., 252, 85, 1975.
27. Bellentani S. and Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J. Hepatol., 35, 531, 2001.
28. Bellentani S. et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med., 132, 112, 2000.
29. Ewusi-Mensah I. et al. The clinical nature and detection of psychiatric disorders in patients with alcoholic liver disease. Alcohol Alcohol., 19, 297, 1984.
30. Sarin S.K. et al. Pattern of psychiatric morbidity and alcohol dependence in patients with alcoholic liver disease. Dig. Dis. Sci., 33, 443, 1988.
31. Gronbaek M. et al. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. Br. Med. J., 317, 844, 1998.
32. Jang M. et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218, 1997.
33. Uenobe F. et al. Antimutagenic effect of resveratrol against Trp-P-1. Mutat. Res., 373, 197, 1997.
34. Roizen R. et al. Cirrhosis mortality and per capita consumption of distilled spirits, United States, 1949-94: trend analysis. Br. Med. J., 319, 666, 1999.
35. Becker U. et al. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology, 35, 868, 2002.
36. Guallar-Castillon P et al. Consumption of alcoholic beverages and subjective health in Spain. J. Epidemiol. Community Health, 55, 648, 2001.
37. Tuyns A.J. and Pequignot G. Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int. J. Epidemiol., 13, 53, 1984.
38. Pares A. et al. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J. Hepatol., 2, 33, 1986.
39. Ashley M.J. et al. Morbidity in alcoholics. Evidence for accelerated development of physical disease in women. Arch. Intern. Med., 137, 883, 1977.
40. Marshall A.W. et al. Ethanol elimination in males and females: relationship to menstrual cycle and body composition. Hepatology, 3, 701, 1983.
41. Frezza M. et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N. Engl. J. Med., 322, 95, 1990.
42. Villa E. et al. Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. Lancet, 2, 1243, 1982.
43. Schiff E.R. Hepatitis C and alcohol. Hepatology, 26, 39S, 1997.
44. Noda K. et al. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma — its relationship to alcohol drinking and the age of transfusion. Alcohol Clin. Exp. Res., 20, 95A, 1996.
45. Imbert-Bismut F. et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet, 357, 1069, 2001.
46. Lonardo A. et al. The bright liver syndrome. Prevalence and determinants of a “bright” liver echopattern. Ital. J. Gastroenterol. Hepatol., 29, 351, 1997.
47. Nomura H. et al. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn. J. Med., 27, 142, 1988.
48. Naveau S. et al. Excess weight risk factor for alcoholic liver disease. Hepatology, 25, 108, 1997.
49. Neuschwander-Tetri B.A. and Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology, 37, 1202, 2003.
50. Reid A.E. Nonalcoholic steatohepatitis. Gastroenterology, 121, 710, 2001.
51. Falck-Ytter Y. et al. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin. Liver Dis., 21, 17, 2001.
52. Angulo P Nonalcoholic fatty liver disease. N. Engl. J. Med., 346, 1221, 2002.
53. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143, 2002.
54. Marchesini G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 37, 917, 2003.
55. Marchesini G. et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 50, 1844, 2001.
56. Pagano G. et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology, 35, 367, 2002.
57. Chitturi S. et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology, 35, 373, 2002.
58. Day C.P Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut, 50, 585, 2002.
59. Day C. and James O. Steatohepatitis: a tale of two “hits”? Gastroenterology, 114, 842, 1998.
60. Chitturi S. et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology, 36, 403, 2002.
61. Musso G. et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology, 37, 909, 2003.